Projects

Validation of 2 wearable activity trackers for physical activity monitoring in Indian pediatric chronic kidney disease

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2026 - 2028

Project Lead

Dr. Arpana Iyengar

Authors

Dr. Arpana Iyengar, Dr. Sucharita Sambashiviah

Project Status

ongoing